Gold Fields Sees Rise In Gold Output For Full Year

Gold Fields Limited (GFI), a South African gold miner, said on Wednesday that it expects a rise in gold production for the fourth-quarter and full-year ended on December 31, 2022.

The miner expects annual gold production of 2,399koz for full year, higher than 2,340koz registered for 2021.

The company has also registered a sequential rise in gold output for fourth-quarter. For the quarter, gold production is expected to be at 601koz, compared with 597koz, recorded for the third-quarter of 2022.

For 2022, Gold Fields expects headline earnings per share (EPS) of $1.16 -1.22, higher than $1 per share of 2021. The increase in headline EPS is driven by the net proceeds relating to the Yamana break fee of $202 million.

For 2022, normalized EPS expected to be in the range of $0.94-$1, lesser than $1.05 per share reported for 2021.

Gold Fields expects to release 2022 financial results on February 23.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT